December 17, 2019 / 11:48 AM / a month ago

Eli Lilly expects higher-than-expected 2020 profit

Dec 17 (Reuters) - Eli Lilly and Co on Tuesday forecast a higher-than-expected profit for 2020, citing growing demand for its medicines including diabetes drug Trulicity and psoriatic arthritis treatment Taltz.

The drugmaker said it expects earnings per share between $6.70 and $6.80 on an adjusted basis for 2020. Analysts were expecting a profit of $6.63 per share, according to Refinitiv IBES data. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shounak Dasgupta)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below